These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 15492284)
21. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
22. The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance. Ikeda T; Sporn M; Honda T; Gribble GW; Kufe D Cancer Res; 2003 Sep; 63(17):5551-8. PubMed ID: 14500394 [TBL] [Abstract][Full Text] [Related]
23. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors. Shenoy K; Wu Y; Pervaiz S Cancer Res; 2009 Mar; 69(5):1941-50. PubMed ID: 19223550 [TBL] [Abstract][Full Text] [Related]
24. The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia. Konopleva M; Tsao T; Estrov Z; Lee RM; Wang RY; Jackson CE; McQueen T; Monaco G; Munsell M; Belmont J; Kantarjian H; Sporn MB; Andreeff M Cancer Res; 2004 Nov; 64(21):7927-35. PubMed ID: 15520199 [TBL] [Abstract][Full Text] [Related]
25. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915 [TBL] [Abstract][Full Text] [Related]
26. Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells. Rabi T; Banerjee S Mol Carcinog; 2008 Jun; 47(6):415-23. PubMed ID: 18058803 [TBL] [Abstract][Full Text] [Related]
27. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781 [TBL] [Abstract][Full Text] [Related]
28. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
29. Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. Lan Y; Liu X; Zhang R; Wang K; Wang Y; Hua ZC Biometals; 2013 Apr; 26(2):241-54. PubMed ID: 23378009 [TBL] [Abstract][Full Text] [Related]
30. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
31. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells. Li F; Meng L; Xing H; Zhou J; Wang S; Huang L; Xu G; Zhu H; Lu Y; Ma D Apoptosis; 2006 Jul; 11(7):1239-46. PubMed ID: 16703262 [TBL] [Abstract][Full Text] [Related]
32. The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway. Elrod HA; Lin YD; Yue P; Wang X; Lonial S; Khuri FR; Sun SY Mol Cancer Ther; 2007 Jul; 6(7):2029-38. PubMed ID: 17604333 [TBL] [Abstract][Full Text] [Related]
34. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer. Odoux C; Albers A; Amoscato AA; Lotze MT; Wong MK Int J Cancer; 2002 Feb; 97(4):458-65. PubMed ID: 11802207 [TBL] [Abstract][Full Text] [Related]
35. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin. Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764 [TBL] [Abstract][Full Text] [Related]
36. Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors. Sung B; Prasad S; Ravindran J; Yadav VR; Aggarwal BB Free Radic Biol Med; 2012 Nov; 53(10):1977-87. PubMed ID: 22922338 [TBL] [Abstract][Full Text] [Related]
37. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
38. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Sinicrope FA; Penington RC Mol Cancer Ther; 2005 Oct; 4(10):1475-83. PubMed ID: 16227396 [TBL] [Abstract][Full Text] [Related]
39. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X; Kandasamy K; Srivastava RK Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723 [TBL] [Abstract][Full Text] [Related]
40. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]